The European MCL Network Phase 3 TRIANGLE study, evaluated ibrutinib in combination with induction immunochemotherapy, both with and without an autologous stem cell transplant, followed by 24 months f ...

Dr Navya Verma Cancer is one of the most dreaded diseases of the 21th century and spreading further with continuance and increasing incidence. It is the third leading cause of death worldwide. It is a ...

Aging induces iron deficiency, reducing stem cell function and tumor growth while enhancing ferroptosis resistance, revealing ...

Molecular Cellular Pharmacology Graduate Program, University of Wisconsin-Madison, Madison, USA Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan ...

NA activity was determined in 96-well white U-bottom microplates (Greiner bio-one GmbH, Frickenhausen, Germany) using the CL-based NA-Star assay (NA-Star Influenza Neuraminidase Inhibitor ...

Chemical inhibition of DHX9 enzymatic activity elicited similar selective effects on cell proliferation as seen with genetic knockdown. In addition, ATX968 induced robust and durable responses in an ...

It’s even on sodas! Labels claim the products “support gut health” or “help boost your immune system.” But is this proliferation of probiotics and prebiotics just marketing or are these microbes ...

functional assay with bone marrow-derived macrophages (BMDMs) shows that ENT significantly enhances tumor cell phagocytosis and antigen presentation, increasing the proliferation of antigen-specific T ...

Revumenib is the first drug in a new class called menin inhibitors to receive FDA approval. The trial that brought about the drug’s approval was led by Eytan Stein, MD, Chief of the Leukemia Service ...

The State Key Laboratory of Chemical Oncogenomics, Institute of Biopharmaceutical and Health Engineering, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, P. R. China The ...